English

ENCYSIVE PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2008-05-12

59 filing records in this dataset, filed from 1996-05-13 to 2008-05-12. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

14.7 million USD

2008-03-31 · USD

Exact inputs and evidence

Revenue: 14711000 USD Source

Operating margin

-53.29%

2008-03-31 · %

Exact inputs and evidence

Operating Income: -7839000 USD Source
Revenue: 14711000 USD Source

Operating cash flow

-17.3 million USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -17287000 USD Source

Cash and cash equivalents: 12.7 million USD 2008-03-31 Source
Exact value

12696000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

45.2 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Revenue: 8937000 USD · 2007-04-01 – 2007-06-30 Source
Revenue: 8785000 USD · 2007-07-01 – 2007-09-30 Source
Revenue: 35922000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 23130000 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 14711000 USD · 2008-01-01 – 2008-03-31 Source

Net income

-82.2 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Net income: -63780000 USD · 2007-01-01 – 2007-06-30 Source
Net income: -29908000 USD · 2007-01-01 – 2007-03-31 Source
Net income: -86303000 USD · 2007-01-01 – 2007-09-30 Source
Net income: -63780000 USD · 2007-01-01 – 2007-06-30 Source
Net income: -100677000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -86303000 USD · 2007-01-01 – 2007-09-30 Source
Net income: -11433000 USD · 2008-01-01 – 2008-03-31 Source

Operating cash flow

-89.4 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Operating cash flow: -57906000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -33991000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -87455000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -57906000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -106137000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -87455000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -17287000 USD · 2008-01-01 – 2008-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-05-12.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2007-12-31
Operating income: 11 of 11 periods available· newest 2007-12-31
Net income: 11 of 11 periods available· newest 2007-12-31
Operating cash flow: 11 of 11 periods available· newest 2007-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2007-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2007-12-31
Current liabilities: 11 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+89.1%

Prior period

USD 19 million

2006-01-01 – 2006-12-31
Current period

USD 35.92 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

35922000 − 18995000 = 16927000 USD

18995000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
35922000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ENCYSIVE PHARMACEUTICALS INC · 2007-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Year-over-year change in Revenue: 16927000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 35922000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#8078 Input fundies:Revenue: 18995000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#8078
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 8.61 million

Prior period

−USD 109.28 million

2006-01-01 – 2006-12-31
Current period

−USD 100.68 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-100677000 − -109283000 = 8606000 USD

-109283000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-100677000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ENCYSIVE PHARMACEUTICALS INC · 2007-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Year-over-year change in Net income: 8606000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -100677000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10433 Input fundies:NetIncome: -109283000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10433
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.68 million

Prior period

−USD 100.46 million

2006-01-01 – 2006-12-31
Current period

−USD 106.14 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-106137000 − -100456000 = -5681000 USD

-100456000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-106137000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ENCYSIVE PHARMACEUTICALS INC · 2007-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Year-over-year change in Operating cash flow: -5681000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -106137000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10773 Input fundies:OperatingCashFlow: -100456000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10773
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 35.92 million 100% of revenue
Operating costs Derived USD 124.74 million 347% of revenue
Operating income −USD 88.82 million −247% of revenue
Tax, interest and other Derived USD 11.86 million 33% of revenue
Net income −USD 100.68 million −280% of revenue

Cash

Operating cash flow −USD 106.14 million −295% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 837% of revenue.
1999 Operating loss: operating costs were 893% of revenue.
2000 Operating loss: operating costs were 150% of revenue.
2001 Operating loss: operating costs were 382% of revenue.
2002 Operating loss: operating costs were 360% of revenue.
2003 Operating loss: operating costs were 420% of revenue.
2004 Operating loss: operating costs were 530% of revenue.
2005 Operating loss: operating costs were 655% of revenue.
2006 Operating loss: operating costs were 675% of revenue.
2007 Operating loss: operating costs were 347% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	2251681	18853560 Derived	-16601879	-2087707 Derived	-14514172	Unavailable	Source 1998-01-01 – 1998-12-31: 2251681 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -16601879 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -14514172 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -13951755 USD Inspect Operating Cash Flow Open source
1999 1999-01-01 – 1999-12-31	2083000	18592000 Derived	-16509000	-1212000 Derived	-15297000	Unavailable	Source 1999-01-01 – 1999-12-31: 2083000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -16509000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -15297000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -15113000 USD Inspect Operating Cash Flow Open source
2000 2000-01-01 – 2000-12-31	15692000	23552000 Derived	-7860000	-2205000 Derived	-5655000	Unavailable	Source 2000-01-01 – 2000-12-31: 15692000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -7860000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -5655000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 2198000 USD Inspect Operating Cash Flow Open source
2001 2001-01-01 – 2001-12-31	8917000	34044000 Derived	-25127000	-5985000 Derived	-19142000	Unavailable	Source 2001-01-01 – 2001-12-31: 8917000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -25127000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -19142000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -12980000 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	10433000	37599000 Derived	-27166000	-3697000 Derived	-23469000	Unavailable	Source 2002-01-01 – 2002-12-31: 10433000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -27166000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -23469000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -25791000 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	10951000	45991000 Derived	-35040000	253000 Derived	-35293000	Unavailable	Source 2003-01-01 – 2003-12-31: 10951000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -35040000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -35293000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -26611000 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	12830000	67998000 Derived	-55168000	-508000 Derived	-54660000	Unavailable	Source 2004-01-01 – 2004-12-31: 12830000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -55168000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -54660000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -49537000 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	14006000	91790000 Derived	-77784000	-2907000 Derived	-74877000	Unavailable	Source 2005-01-01 – 2005-12-31: 14006000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -77784000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -74877000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -66081000 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	18995000	128276000 Derived	-109281000	2000 Derived	-109283000	Unavailable	Source 2006-01-01 – 2006-12-31: 18995000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -109281000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -109283000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -100456000 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	35922000	124738000 Derived	-88816000	11861000 Derived	-100677000	Unavailable	Source 2007-01-01 – 2007-12-31: 35922000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -88816000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -100677000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -106137000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 35.9M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	2251681	Revenue: 2251681 Open source
19991999-12-31	Revenue	2083000	Revenue: 2083000 Open source
20002000-12-31	Revenue	15692000	Revenue: 15692000 Open source
20012001-12-31	Revenue	8917000	Revenue: 8917000 Open source
20022002-12-31	Revenue	10433000	Revenue: 10433000 Open source
20032003-12-31	Revenue	10951000	Revenue: 10951000 Open source
20042004-12-31	Revenue	12830000	Revenue: 12830000 Open source
20052005-12-31	Revenue	14006000	Revenue: 14006000 Open source
20062006-12-31	Revenue	18995000	Revenue: 18995000 Open source
20072007-12-31	Revenue	35922000	Revenue: 35922000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

89.1% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	-86.7%	Revenue: 2251681 Open source Revenue: 16907780 Open source
19991999-12-31	Year over year	-7.5%	Revenue: 2083000 Open source Revenue: 2251681 Open source
20002000-12-31	Year over year	653.3%	Revenue: 15692000 Open source Revenue: 2083000 Open source
20012001-12-31	Year over year	-43.2%	Revenue: 8917000 Open source Revenue: 15692000 Open source
20022002-12-31	Year over year	17%	Revenue: 10433000 Open source Revenue: 8917000 Open source
20032003-12-31	Year over year	5%	Revenue: 10951000 Open source Revenue: 10433000 Open source
20042004-12-31	Year over year	17.2%	Revenue: 12830000 Open source Revenue: 10951000 Open source
20052005-12-31	Year over year	9.2%	Revenue: 14006000 Open source Revenue: 12830000 Open source
20062006-12-31	Year over year	35.6%	Revenue: 18995000 Open source Revenue: 14006000 Open source
20072007-12-31	Year over year	89.1%	Revenue: 35922000 Open source Revenue: 18995000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -247.2% 2007

Net margin -280.3% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-737.3%	Operating Income: -16601879 Open source Revenue: 2251681 Open source
19991999-12-31	Operating margin	-792.6%	Operating Income: -16509000 Open source Revenue: 2083000 Open source
20002000-12-31	Operating margin	-50.1%	Operating Income: -7860000 Open source Revenue: 15692000 Open source
20012001-12-31	Operating margin	-281.8%	Operating Income: -25127000 Open source Revenue: 8917000 Open source
20022002-12-31	Operating margin	-260.4%	Operating Income: -27166000 Open source Revenue: 10433000 Open source
20032003-12-31	Operating margin	-320%	Operating Income: -35040000 Open source Revenue: 10951000 Open source
20042004-12-31	Operating margin	-430%	Operating Income: -55168000 Open source Revenue: 12830000 Open source
20052005-12-31	Operating margin	-555.4%	Operating Income: -77784000 Open source Revenue: 14006000 Open source
20062006-12-31	Operating margin	-575.3%	Operating Income: -109281000 Open source Revenue: 18995000 Open source
20072007-12-31	Operating margin	-247.2%	Operating Income: -88816000 Open source Revenue: 35922000 Open source
19981998-12-31	Net margin	-644.6%	Net Income: -14514172 Open source Revenue: 2251681 Open source
19991999-12-31	Net margin	-734.4%	Net Income: -15297000 Open source Revenue: 2083000 Open source
20002000-12-31	Net margin	-36%	Net Income: -5655000 Open source Revenue: 15692000 Open source
20012001-12-31	Net margin	-214.7%	Net Income: -19142000 Open source Revenue: 8917000 Open source
20022002-12-31	Net margin	-224.9%	Net Income: -23469000 Open source Revenue: 10433000 Open source
20032003-12-31	Net margin	-322.3%	Net Income: -35293000 Open source Revenue: 10951000 Open source
20042004-12-31	Net margin	-426%	Net Income: -54660000 Open source Revenue: 12830000 Open source
20052005-12-31	Net margin	-534.6%	Net Income: -74877000 Open source Revenue: 14006000 Open source
20062006-12-31	Net margin	-575.3%	Net Income: -109283000 Open source Revenue: 18995000 Open source
20072007-12-31	Net margin	-280.3%	Net Income: -100677000 Open source Revenue: 35922000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 2251681 Open source Operating Cash Flow: -13951755 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 2083000 Open source Operating Cash Flow: -15113000 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 15692000 Open source Operating Cash Flow: 2198000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 8917000 Open source Operating Cash Flow: -12980000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 10433000 Open source Operating Cash Flow: -25791000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 10951000 Open source Operating Cash Flow: -26611000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 12830000 Open source Operating Cash Flow: -49537000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 14006000 Open source Operating Cash Flow: -66081000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 18995000 Open source Operating Cash Flow: -100456000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 35922000 Open source Operating Cash Flow: -106137000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -106.1M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-13951755	Operating Cash Flow: -13951755 Open source
19991999-12-31	Operating cash flow	-15113000	Operating Cash Flow: -15113000 Open source
20002000-12-31	Operating cash flow	2198000	Operating Cash Flow: 2198000 Open source
20012001-12-31	Operating cash flow	-12980000	Operating Cash Flow: -12980000 Open source
20022002-12-31	Operating cash flow	-25791000	Operating Cash Flow: -25791000 Open source
20032003-12-31	Operating cash flow	-26611000	Operating Cash Flow: -26611000 Open source
20042004-12-31	Operating cash flow	-49537000	Operating Cash Flow: -49537000 Open source
20052005-12-31	Operating cash flow	-66081000	Operating Cash Flow: -66081000 Open source
20062006-12-31	Operating cash flow	-100456000	Operating Cash Flow: -100456000 Open source
20072007-12-31	Operating cash flow	-106137000	Operating Cash Flow: -106137000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13951755 Open source
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: -15113000 Open source
20002000-12-31	Free cash flow	Unavailable	Operating Cash Flow: 2198000 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -12980000 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -25791000 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -26611000 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -49537000 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -66081000 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -100456000 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -106137000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	Total Assets: 36105980 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 20804691 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 98969000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 104362000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 77792000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 94398000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 80772000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 146702000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 63137000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 58698000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.5× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Current assets / current liabilities	10.72×	Current Assets: 30776951 Open source Current Liabilities: 2869760 Open source
19991999-12-31	Current assets / current liabilities	7.54×	Current Assets: 16691164 Open source Current Liabilities: 2214370 Open source
20002000-12-31	Current assets / current liabilities	0.09×	Current Assets: 491000 Open source Current Liabilities: 5592000 Open source
20012001-12-31	Current assets / current liabilities	7.54×	Current Assets: 60318000 Open source Current Liabilities: 7996000 Open source
20022002-12-31	Current assets / current liabilities	8.2×	Current Assets: 51207000 Open source Current Liabilities: 6242000 Open source
20032003-12-31	Current assets / current liabilities	5.84×	Current Assets: 86804000 Open source Current Liabilities: 14869000 Open source
20042004-12-31	Current assets / current liabilities	4.77×	Current Assets: 75114000 Open source Current Liabilities: 15758000 Open source
20052005-12-31	Current assets / current liabilities	5.25×	Current Assets: 137249000 Open source Current Liabilities: 26151000 Open source
20062006-12-31	Current assets / current liabilities	1.99×	Current Assets: 53419000 Open source Current Liabilities: 26854000 Open source
20072007-12-31	Current assets / current liabilities	2.5×	Current Assets: 48863000 Open source Current Liabilities: 19540000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 14.51 million Exact value Exact value: -14514172 USD 1998-01-01 – 1998-12-31: -14514172 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 1998-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -14514172 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14514172 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-01-001871.txt#3231 The citation records this snapshot. The page link may show a newer release later.	−USD 13.95 million Exact value Exact value: -13951755 USD 1998-01-01 – 1998-12-31: -13951755 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 1998-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -13951755 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13951755 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-01-001871.txt#3257 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 15.3 million Exact value Exact value: -15297000 USD 1999-01-01 – 1999-12-31: -15297000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 1999-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -15297000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15297000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-02-001633.txt#3312 The citation records this snapshot. The page link may show a newer release later.	−USD 15.11 million Exact value Exact value: -15113000 USD 1999-01-01 – 1999-12-31: -15113000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 1999-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -15113000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15113000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-02-001633.txt#3335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 5.66 million Exact value Exact value: -5655000 USD 2000-01-01 – 2000-12-31: -5655000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2000-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -5655000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5655000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-03-005675.txt#4131 The citation records this snapshot. The page link may show a newer release later.	USD 2.2 million Exact value Exact value: 2198000 USD 2000-01-01 – 2000-12-31: 2198000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2000-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: 2198000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2198000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-03-005675.txt#4153 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 19.14 million Exact value Exact value: -19142000 USD 2001-01-01 – 2001-12-31: -19142000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2001-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -19142000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19142000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-04-001318.txt#3507 The citation records this snapshot. The page link may show a newer release later.	−USD 12.98 million Exact value Exact value: -12980000 USD 2001-01-01 – 2001-12-31: -12980000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2001-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -12980000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12980000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-04-001318.txt#3530 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 23.47 million Exact value Exact value: -23469000 USD 2002-01-01 – 2002-12-31: -23469000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2002-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -23469000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23469000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-05-002133.txt#10006 The citation records this snapshot. The page link may show a newer release later.	−USD 25.79 million Exact value Exact value: -25791000 USD 2002-01-01 – 2002-12-31: -25791000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2002-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -25791000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25791000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-05-002133.txt#10321 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 35.29 million Exact value Exact value: -35293000 USD 2003-01-01 – 2003-12-31: -35293000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2003-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -35293000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35293000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-06-002524.txt#9831 The citation records this snapshot. The page link may show a newer release later.	−USD 26.61 million Exact value Exact value: -26611000 USD 2003-01-01 – 2003-12-31: -26611000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2003-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -26611000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26611000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-06-002524.txt#10233 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 54.66 million Exact value Exact value: -54660000 USD 2004-01-01 – 2004-12-31: -54660000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2004-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -54660000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54660000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-07-001433.txt#3804 The citation records this snapshot. The page link may show a newer release later.	−USD 49.54 million Exact value Exact value: -49537000 USD 2004-01-01 – 2004-12-31: -49537000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2004-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -49537000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -49537000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-07-001433.txt#4129 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 74.88 million Exact value Exact value: -74877000 USD 2005-01-01 – 2005-12-31: -74877000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2005-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -74877000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74877000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10433 The citation records this snapshot. The page link may show a newer release later.	−USD 66.08 million Exact value Exact value: -66081000 USD 2005-01-01 – 2005-12-31: -66081000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2005-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -66081000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -66081000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10773 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 109.28 million Exact value Exact value: -109283000 USD 2006-01-01 – 2006-12-31: -109283000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2006-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -109283000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -109283000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10433 The citation records this snapshot. The page link may show a newer release later.	−USD 100.46 million Exact value Exact value: -100456000 USD 2006-01-01 – 2006-12-31: -100456000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2006-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -100456000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -100456000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10773 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 100.68 million Exact value Exact value: -100677000 USD 2007-01-01 – 2007-12-31: -100677000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENCYSIVE PHARMACEUTICALS INC · 2007-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Net Income: -100677000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -100677000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10433 The citation records this snapshot. The page link may show a newer release later.	−USD 106.14 million Exact value Exact value: -106137000 USD 2007-01-01 – 2007-12-31: -106137000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENCYSIVE PHARMACEUTICALS INC · 2007-12-31 ENCYSIVE PHARMACEUTICALS INC (edgar:887023) Operating Cash Flow: -106137000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T22:24:31Z Snapshot: a591dc19fe43389e012038ffd1aa2fc80164107ad2e573441ee42ec0dff7cdac Dimensions: Consolidated View: https://fundies.io/companies/edgar/887023/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -106137000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887023/0000950129-08-001756.txt#10773 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

59 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000887023, 887023, edgar:887023

Also known as TEXAS BIOTECHNOLOGY CORP /DE/

ENCYSIVE PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation